Base Ten Systems: Completes private placement of approximately $10 mil. principal amount of 9.01% convertible debentures. Proceeds will go toward further development of the Trenton, New Jersey firm's Pharmasyst and Pharm2 software systems for medical device and pharmaceutical product manufacturing and its uPACS ultrasound picture archiving and communication system as well as for working capital. Andrew Garrett, Inc. was agent for the placement. Having met its near term financing needs, the firm is withdrawing a registration statement filed June 19 for an offering of 2 mil. shares of Class A common stock, the firm states...
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
Point of care ultrasound technology that can be used by non-sonographers will plug gaps in workforce coverage and bring new critical care capabilities to the frontline of care, said Royal Philips.
The new AI Precision Medicine platform supports the company’s flagship product, EvoLiver, which received US FDA breakthrough device designation in April.
16 June marked the first major new regulatory instrument in the UK’s post-Brexit transition to a standalone device regulatory system for Great Britain.
